At a glance
- Originator Bayer Schering Pharma
- Class
- Mechanism of Action Estrogen receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pregnancy
Most Recent Events
- 08 Dec 1998 No-Development-Reported for Pregnancy (Prevention) in Germany (PO)
- 17 Jan 1997 New profile
- 17 Jan 1997 Phase-I clinical trials for Pregnancy (Prevention) in Germany (PO)